Epigenetic MCL-1 Targeting in Glioblastoma
2026-08-20
The reference study identifies a super-enhancer at the MCL1 locus as a functional vulnerability in glioblastoma and shows that disrupting MCL-1 expression sensitizes tumors to BCL-2/BCL-XL inhibition. Its combination of ChIP-seq, pharmacologic testing, apoptosis assays, and patient-derived xenograft models provides a mechanistic framework for studying synthetic lethality in apoptotic-resistant GBM.
Entinostat: A Temporal HDAC Assay Strategy
2026-08-19
Entinostat (MS-275) is more than a class I HDAC inhibitor: it can function as a temporally controlled perturbation tool for separating target engagement from tissue-level phenotypes. This article connects cancer epigenetics with axolotl regeneration research while translating the evidence into practical assay decisions.
Aurora A Overexpression in High-Risk Retinoblastoma
2026-08-19
A 2024 American Journal of Pathology study identifies Aurora kinase A as a consistently elevated and clinically informative feature of human retinoblastoma. By combining patient-specimen analysis with genetic, pharmacologic, patient-derived, and xenograft models, the work links AURKA to high-risk histopathology, chemotherapy resistance, and MYCN regulation.
Anlotinib hydrochloride: Angiogenesis Assay Workflows
2026-08-18
Turn receptor-level inhibition into practical endothelial migration, tube formation, and ERK readouts with a concentration-aware workflow. Anlotinib hydrochloride supports anti-angiogenic assay design while helping distinguish pathway suppression from nonspecific cytotoxicity.
Tacalcitol monohydrate: Applied Research Workflows
2026-08-18
Tacalcitol monohydrate connects VDR-directed keratinocyte biology with measurable NGF induction and exploratory colorectal cancer combination studies. This workflow-focused guide covers dosing, assay timing, 5-fluorouracil pairing, formulation controls, and troubleshooting for reproducible bench research.
Anti Reverse Cap Analog for TCAIM Assays
2026-08-17
Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, can strengthen controlled mRNA expression experiments designed to test the TCAIM–OGDH mitochondrial regulatory axis. This article connects cap chemistry with assay design, emphasizing causal controls, translation initiation, and the limits of translating a mechanistic paper into an mRNA workflow.
MVC Activates RhoA/ROCK1 to Disrupt Tight Junctions
2026-08-16
Ren et al. identify a previously unreported entry mechanism in which MVC VP2 associates with ROCK1 and activates the RhoA/ROCK1/MLC2 axis, causing tight-junction remodeling and occludin exposure. The work connects cytoskeletal contraction with viral uptake and provides a mechanistic basis for testing pathway-directed interventions in canine infection models.
Carbenoxolone disodium Protocol Guide
2026-08-15
Carbenoxolone disodium is a practical research tool for perturbing 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in cell- and tissue-based experiments. It is best used for mechanistic studies with local pilot optimization, not as a selective in vivo efficacy agent or as a probe when off-target effects cannot be controlled.
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO)
2026-08-15
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) helps limit endogenous proteolysis during cell lysis and protein sample preparation for assays such as Western blotting, co-immunoprecipitation, and kinase analysis. Its EDTA-free formulation is useful when divalent cations must remain available, but it should not be treated as a universal substitute for metal-chelation or phosphatase-inhibition strategies.
RITA (NSC 652287): Read the Response Correctly
2026-08-14
RITA (NSC 652287) is an MDM2-p53 pathway probe whose apparent potency can reflect both growth arrest and cell killing. This guide translates a dual-metric assay framework into practical strategies for interpreting RITA in cancer biology and renal carcinoma research.
Tacalcitol Monohydrate: From VDR to Assay Design
2026-08-14
Tacalcitol monohydrate is a synthetic analog of vitamin D3 that links VDR biology with practical assay design. This evidence-led guide explains how to study NGF induction, psoriasis-relevant keratinocyte responses, and 5-fluorouracil sensitization in colorectal cancer models.
BBB Permeability Prediction with Lysosomal Correction
2026-08-13
Hu et al. developed a high-throughput Transwell blood-brain barrier surrogate that combines LLC-PK1-MOCK and LLC-PK1-MDR1 cells with a correction for lysosomal drug trapping. Across 41 compounds, the workflow linked in vitro permeability to unbound brain distribution and improved interpretation of compounds affected by intracellular sequestration.
Amphotericin B in Candida Biofilm Research
2026-08-13
Build a controlled workflow for testing Amphotericin B against planktonic Candida and mature biofilms, while separating direct membrane killing from autophagy-linked resistance. This guide translates the latest PP2A–ATG findings into assay design, comparator selection, troubleshooting, and defensible interpretation.
Pazopanib (GW-786034) in Cancer Research
2026-08-12
Pazopanib, also called GW-786034, is an oral multi-targeted receptor tyrosine kinase inhibitor used to study VEGFR, PDGFR, FGFR, c-Kit, and c-Fms signaling. Its reported anti-angiogenic activity, tumor growth suppression, and relevance to ATRX-deficient glioma models make it a useful tool for cancer research, but catalog potency values do not replace assay-specific validation.
Cy3-dCTP for Direct Fluorescent DNA Labeling
2026-08-12
Cy3-dCTP enables direct fluorescent labeling during PCR, reverse transcription, and Nick Translation rather than requiring a separate dye-coupling step. This workflow-focused guide shows how to balance signal, polymerase performance, probe quality, and assay compatibility for hybridization, microarray, blotting, and multicolor applications.
459 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page